Location History:
- Molndal, SE (2014)
- Uppsala, SE (2015)
Company Filing History:
Years Active: 2014-2015
Title: The Innovative Contributions of AnnaCarin Wallgren
Introduction
AnnaCarin Wallgren, based in Uppsala, Sweden, stands out as a prominent inventor in the field of immunotherapy. With a significant focus on cancer research, she has developed innovative solutions that contribute to modern medical treatments. Her impressive portfolio includes two patented inventions that showcase her dedication and expertise in combating tumor growth.
Latest Patents
AnnaCarin Wallgren's latest patents include the following:
1. **Composition for Inhibiting Tumor Cell Proliferation**: This invention pertains to cancer immunotherapy, offering a proinflammatory dendritic cell (DC) that has been stimulated to maturation ex vivo through specific treatment. This method, alongside a composition comprising the proinflammatory DC, can be utilized as a cell-based immunotherapy to inhibit tumor cell proliferation.
2. **Method and Composition for Producing a Cellular Allogeneic Vaccine**: This invention relates to a method for producing a cellular allogeneic vaccine that is based on an allogeneic antigen-presenting cell (APC). This innovative approach involves several steps aimed at enhancing the efficacy of cellular vaccines in clinical settings.
Career Highlights
Wallgren is employed at Immunicum AB, a company that specializes in developing innovative immunotherapy treatments. Her work focuses on advancing treatments that harness the power of the immune system to fight cancer, reflecting her commitment to transforming patient outcomes through scientific research and innovation.
Collaborations
Throughout her career, AnnaCarin Wallgren has collaborated with notable professionals including Alex Karlsson-Parra and Bengt Andersson. These partnerships have contributed to the advancement of her research and have facilitated valuable contributions to the field of immunotherapy.
Conclusion
AnnaCarin Wallgren's contributions as an inventor in the realm of cancer immunotherapy represent significant strides in the fight against cancer. With her innovative patents and collaborative efforts, she continues to pave the way for new therapeutic strategies that hold promise for improving patient outcomes. Her dedication to research exemplifies the vital role of inventors in the advancement of medicine.